文献速递心脑血管急症重症综合管理与镇静镇痛

TEAD1 敲低通过调控 MMP3 抑制脑缺血再灌注中的炎症与铁死亡

TEAD1 KNOCKDOWN IMPEDES THE INFLAMMATION AND FERROPTOSIS BY MEDIATING MMP3 IN CEREBRAL ISCHEMIA REPERFUSION.
PubMed 文献 · Shock · 2025-03-17
一句话结论体外与大鼠模型显示 TEAD1 靶向 MMP3 促进脑缺血再灌注炎症与铁死亡,敲低 TEAD1 可经降低 MMP3 减轻损伤。

研究聚焦 TEAD1 与 MMP3 在脑缺血再灌注(IR)损伤中的分子机制。体外以氧糖剥夺/复氧(OGD/R)处理人脑微血管内皮细胞(HBMVECs),体内采用大鼠大脑中动脉闭塞-再灌注(MCAO/R)模型。结果显示 OGD/R 诱导 HBMVECs 中 MMP3 明显上调,敲低 MMP3 可减轻凋亡、炎症与铁死亡;TEAD1 通过靶向 MMP3 启动子增强其表达,沉默 TEAD1 经降低 MMP3 抑制 OGD/R 介导的炎症与铁死亡。MCAO/R 模型中抑制 TEAD1 通过影响 MMP3 保护大鼠脑组织。作者认为 TEAD1/MMP3 轴参与脑 IR 损伤。

要点

  • OGD/R 处理的人脑微血管内皮细胞(HBMVECs)中 MMP3 明显上调。
  • 敲低 MMP3 后,OGD/R 处理的 HBMVECs 凋亡、炎症与铁死亡均减轻。
  • TEAD1 通过靶向 MMP3 启动子增强 MMP3 表达;沉默 TEAD1 经降低 MMP3 抑制 OGD/R 介导的炎症与铁死亡。
  • 大鼠 MCAO/R 模型中抑制 TEAD1 通过影响 MMP3 保护脑组织。
  • 作者认为 TEAD1/MMP3 轴参与脑缺血再灌注损伤。

适用人群与场景

  • 体外:人脑微血管内皮细胞(HBMVECs)氧糖剥夺/复氧(OGD/R)模型。
  • 体内:大鼠大脑中动脉闭塞-再灌注(MCAO/R)模型。

研究设计与关键结果

  • 研究类型:体外细胞实验与体内大鼠模型结合的机制研究。
  • 体外:OGD/R 诱导 HBMVECs 中 MMP3 明显上调;敲低 MMP3 后 OGD/R 处理细胞的凋亡、炎症与铁死亡均减轻。
  • 机制:RNA 免疫沉淀实验证明 TEAD1 与 MMP3 相互作用;TEAD1 通过靶向 MMP3 启动子增强 MMP3 表达;沉默 TEAD1 经降低 MMP3 抑制 OGD/R 介导的炎症与铁死亡。
  • 体内:MCAO/R 模型中抑制 TEAD1 通过影响 MMP3 保护大鼠脑组织;脑损伤评估采用氯化三苯基四氮唑染色、伊文思蓝渗出、神经功能评分与脑含水量检测。

证据类型、等级与局限

  • 证据类型:体外细胞实验与大鼠在体机制研究。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 原文为机制研究,未据此给出临床推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Background: Cerebral ischemia-reperfusion (IR) injury is a frequent complication of ischemic stroke with the adverse impact on the clinical prognosis. This study focused on the molecular mechanism associated with TEA domain transcription factor 1 (TEAD1) and matrix metalloproteinase 3 (MMP3) in cerebral IR. Methods:In vitro , IR model was established using oxygen-glucose deprivation/reoxygenation (OGD/R) in human brain microvascular endothelial cells (HBMVECs). TEAD1 and MMP3 mRNA and protein examination were performed by RT-qPCR and western blot. Cell viability and apoptosis were measured using cell counting kit-8 assay and flow cytometry. Enzyme-linked immunosorbent assay was conducted for detection of inflammatory cytokines. Ferroptosis was evaluated via kits. TEAD1 and MMP3 interaction was proved by RNA immunoprecipitation assay. In vivo , IR was induced in rats by middle cerebral artery occlusion-reperfusion (MCAO/R) model. Brain injury in rats was assessed by tetrazolium chloride staining, Evans blue extravasation, neurological function score, and cerebral water content detection. Results: OGD/R-induced the prominent upregulation of MMP3 in HBMVECs. After knockdown of MMP3, apoptosis, inflammation and ferroptosis were all mitigated in OGD/R-treated HBMVECs. TEAD1 could enhance MMP3 expression by targeting the promoter. TEAD1 silence impeded OGD/R-mediated inflammation and ferroptosis via reducing MMP3. In MCAO/R model, TEAD1 inhibition protected brain tissues of rats against cerebral IR injury by affecting MMP3. Conclusion: The above evidence elucidated that TEAD1 facilitated cerebra inflammation and ferroptosis in vitro and in vivo IR models through targeting MMP3, suggesting the involvement of TEAD1/MMP3 axis in cerebral IR injury.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Lu J, Su J, Zhu L, et al. TEAD1 KNOCKDOWN IMPEDES THE INFLAMMATION AND FERROPTOSIS BY MEDIATING MMP3 IN CEREBRAL ISCHEMIA REPERFUSION. Shock. 2025. PMID: 40138721. doi:10.1097/SHK.0000000000002589

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。